EMCC European Monitoring Centre on Change

Lek

Company/Organisation:
Lek

Geographic Location

Country: Slovenia
Region: Koroska; Slovenija
Location of affected unit(s): Prevalje

Company

Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.10 - Manufacture of basic pharmaceutical products
Number Employed: 3793
Group: Sandoz

Employment Effects

Announcement Date: 01-10-2019
Planned Job Reductions min: 320
Planned Job Reductions max: 320
Type of Restructuring: Relocation
Employment Effect Start: 01-12-2019
Foreseen End Date: 01-12-2021
Direct Dismissals: 250
Other Job Reduction Measures: 70

Additional Information

Pharmaceutical company Lek from Ljubljana, a subsidiary of Swiss-based Sandoz group, will cease antibiotic production at its Prevalje plant by late 2021. The production will be relocated to Kundl in Austria, so 250 employees and 70 agency workers will lose their jobs. The site will have a new role as Novartis plans to set up a centre for global operations in Slovenia, carrying out logistics, supply chain, purchasing, quality control, production science, technology and engineering. Novartis has ensured that all employees will be able to requalify.

Sources: